Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Input search
Clear search input
×
bio-convergence
Advertisement
July 12, 2023, 8:12 pm
Israel earmarks NIS 113 million to build R&D center for chip-based biodevices
Israel Innovation Authority will fund R&D infrastructure for the development of biodevices such as environmental diagnostic sensors and smart implants for medical treatment
By
Sharon Wrobel
July 10, 2023, 9:00 pm
Robotic deliveries, 3D-printed organs: Israel seeks to bring the future closer
Israel Innovation Authority launches NIS 40 million initiative to fund startups developing tech in three areas: autonomous home deliveries, bio-convergence and school safety
By
Sharon Wrobel
December 29, 2020, 12:41 pm
Pfizer, AstraZeneca chosen for lab to foster Israel biotech startups
Consortium of pharma and tech giants, including Merck, Teva, Amazon, will run new innovation lab to develop ecosystem, tap into new tech
By
Shoshanna Solomon
July 19, 2020, 3:45 pm
Anya Eldan
Israel is spearheading a ‘bio-convergence’ revolution
The nascent field fuses life sciences with technologies from mathematics, engineering, and the physical and computational sciences, creating a sum far greater than its parts
July 12, 2020, 1:33 am
Israel seeks edge at intersection of biology with engineering, AI
Israel Innovation Authority announces NIS 13.5 million ($3.9 million) bio-convergence program to fund multidisciplinary medical projects with commercial potential
By
Shoshanna Solomon
Load More
Advertisement
close popup
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Email address
*
Please use the following structure: example@domain.com
Continue
Or Continue with
By joining you agree to the
terms and conditions
back
close popup
Register to continue
Email address
*
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
*
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Join The Times of Israel Community
You are currently registered. Please join The Times of Israel Community to comment and enjoy other Community benefits
Only ToI Community members can comment below articles
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Forgot your password?
/
Send me a login link
Continue
Sign in without joining
Or Continue with
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete registration so you can comment.
back
close popup
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Email address
*
Please use the following structure: example@domain.com
JOIN NOW!
close popup
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to
. Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.